SDZ.SW stock up after FY2025 biosimilars surge on SIX intraday: 1-year upside 24.30%
SDZ.SW stock is trading at CHF 65.64 on the SIX intraday session on 26 Feb 2026 after a sharp move driven by FY2025 results that highlighted strong biosimilars growth. Volume is elevated at 1,118,979.00 shares, above the 50-day average of 740,380.00, signalling heavy trader interest. We examine valuation, technicals and Meyka AI model forecasts to explain why Sandoz Group AG (SDZ.SW) is a top gainer and what to watch next.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →